Latest news

PR Newswire | 2022-11-11

Fierce Biotech | 2022-11-08

PR Newswire | 2022-11-08

FiercePharma  | 2022-10-25

Biz Journals | 2022-10-20

Post Bulletin | 2022-10-20

EXCERPT:  “Today’s Investment in Healing Conference brought together key collaborators who are playing a pivotal role in the creation of a dynamic platform ecosystem,” wrote Mayo Clinic President and CEO Dr. Gianrico Farrugia.

Mayo Clinic News Network | 2022-10-12

Healthcare IT News | 2022-10-03

MobiHealthNews | 2022-09-21

BioSpace | 2022-09-20

EXCERPT:  MoatBio holds an exclusive patent license from Mayo Clinic for the novel second generation single-cycle adenovirus vaccine platform (SC-AdVax) to develop intranasal and oral vaccines that can elicit and boost both mucosal and systemic immunity for the treatment of infectious diseases, like COVID-19. 

Twin Cities Business | 2022-09-01

EXCERPT: Mayo Clinic Ventures chair Andrew Danielsen estimated that the accelerator will give birth to about one to three new companies a year.

Mayo Clinic News Network | 2022-08-31

PR Newswire | 2022-08-30

PR Newswire | 2022-08-29

Fierce Pharma | 2022-08-18

Mayo Clinic News Network | 2022-08-15

Mass Device | 2022-08-01

EXCERPT: Mayo Clinic participated, making the Israel-based firm a Mayo Clinic portfolio company.

Business Wire  | 2022-07-20

Mayo Clinic News Network  | 2022-07-19

Med City News | 2022-07-15

EXCERPT: Anumana was formed by Mayo Clinic and nference, a company that uses unstructured electronic medical records data from medical centers to develop new diagnostics and treatments.

Fierce Biotech | 2022-07-14

Business Wire  | 2022-06-28

Mayo Clinic News Network | 2022-06-21

Fierce Healthcare  | 2022-06-20

Mass Devices  | 2022-05-24

EXCERPT: The algorithm is Anumana’s second to receive a breakthrough nod, with its low ejection fraction algorithm (developed by Mayo Clinic and licensed by Anumana) garnering approval in 2019, plus FDA emergency use authorization (EUA) for COVID-19 in 2020.